Pantoprazole
- Generic Name
- Pantoprazole
- Brand Names
- Protonix, Somac Control, Tecta, Pantozol Control, Controloc Control
- Drug Type
- Small Molecule
- Chemical Formula
- C16H15F2N3O4S
- CAS Number
- 102625-70-7
- Unique Ingredient Identifier
- D8TST4O562
- Background
Pantoprazole is a first-generation proton pump inhibitor (PPI) used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be...
- Indication
Pantoprazole Injection:
Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis
...
- Associated Conditions
- Erosive Esophagitis, GERD With Erosive Esophagitis, Gastro-esophageal Reflux Disease (GERD), Healing, Heartburn, Helicobacter Pylori Infection, Stress Ulcers, Zollinger-Ellison Syndrome, Conditions where a reduction of gastric acid secretion is required, Pathological hypersecretory conditions
- Associated Therapies
- -
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
- Conditions
- Interventions
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- United States Naval Medical Center, Portsmouth
- Target Recruit Count
- 132
- Registration Number
- NCT06488001
- Locations
- 🇺🇸
Naval Medical Center Portsmouth, Portsmouth, Virginia, United States
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
- First Posted Date
- 2023-12-04
- Last Posted Date
- 2024-12-02
- Target Recruit Count
- 100
- Registration Number
- NCT06154226
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 56
- Registration Number
- NCT05251233
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
A Study to Explore the Effect of Acid-reducing Agents
- Conditions
- Interventions
- First Posted Date
- 2021-06-22
- Last Posted Date
- 2022-08-26
- Lead Sponsor
- Mirati Therapeutics Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04935112
- Locations
- 🇺🇸
Covance Clinical Research Unit Inc., Madison, Wisconsin, United States
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 2600
- Registration Number
- NCT04728516
- Locations
- 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China
🇨🇳The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Effect of Obesity on Proton Pump Inhibitors
- Conditions
- Interventions
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Children's Mercy Hospital Kansas City
- Target Recruit Count
- 150
- Registration Number
- NCT04248335
- Locations
- 🇺🇸
Children's Mercy Kansas City, Kansas City, Missouri, United States
Efficacy of DA-5204 on Gastroesophageal Reflux Disease
- Conditions
- Interventions
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT03998969
- Locations
- 🇰🇷
Seoul National University Bungdang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function
- First Posted Date
- 2019-04-10
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 200
- Registration Number
- NCT03910647
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
- Conditions
- Interventions
- First Posted Date
- 2019-04-09
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 232
- Registration Number
- NCT03908593
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
- Conditions
- Interventions
- First Posted Date
- 2017-12-15
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- McMaster University
- Target Recruit Count
- 4800
- Registration Number
- NCT03374800
- Locations
- 🇨🇦
Hamilton Health Science Center - General Hospital, Hamilton, Ontario, Canada
🇦🇺Royal Melbourne Hospital, Melbourne, Victoria, Australia
🇧🇷Sociedade Hospitalar Angelina Caron, Campina Grande Do Sul, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.